These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16109506)

  • 61. Blood saving protocol in elective total knee arthroplasty.
    Kourtzis N; Pafilas D; Kasimatis G
    Am J Surg; 2004 Feb; 187(2):261-7. PubMed ID: 14769316
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effect of blood conservation in open-heart surgery: a comparison of 3 different methods].
    Yoshikawa Y; Niwaya K; Hasegawa J; Kobayashi S; Morita R; Kawauchi K; Kitamura S
    Kyobu Geka; 1994 Dec; 47(13):1059-62. PubMed ID: 7830353
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A randomized, parallel-group, open-label trial of recombinant human erythropoietin vs preoperative autologous donation in primary total joint arthroplasty: effect on postoperative vigor and handgrip strength.
    Keating EM; Callaghan JJ; Ranawat AS; Bhirangi K; Ranawat CS
    J Arthroplasty; 2007 Apr; 22(3):325-33. PubMed ID: 17400086
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The use of recombinant human erythropoietin stimulating factor in plastic surgery.
    Ferraro GA; Corcione A; Nicoletti GF; Brongo S; Ciccarelli F; D'Andrea F
    Aesthetic Plast Surg; 2004; 28(3):174-6. PubMed ID: 15383887
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317].
    Georgopoulos D; Matamis D; Routsi C; Michalopoulos A; Maggina N; Dimopoulos G; Zakynthinos E; Nakos G; Thomopoulos G; Mandragos K; Maniatis A;
    Crit Care; 2005 Oct; 9(5):R508-15. PubMed ID: 16277712
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [High-dose induction therapy followed by maintenance with recombinant human erythropoietin for 30 patients with tumor-related anemia].
    Xu F; Zhang L; Xiang XJ; Wang ZQ; Zhou ZM; Wang SY
    Ai Zheng; 2006 Sep; 25(9):1120-2. PubMed ID: 16965653
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of recombinant hematopoietins on blood-loss anemia in mice.
    Jones KB; Anderson DW; Longmore GD
    Iowa Orthop J; 2005; 25():129-34. PubMed ID: 16089085
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement.
    Cuenca J; García-Erce JA; Martínez F; Cardona R; Pérez-Serrano L; Muñoz M
    Int J Surg; 2007 Apr; 5(2):89-94. PubMed ID: 17448971
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Which patients are more likely to benefit from postoperative shed blood salvage after unilateral total knee replacement? An analysis of 581 consecutive procedures.
    Muñoz M; Kühlmorgen B; Ariza D; Haro E; Marroquí A; Ramirez G
    Vox Sang; 2007 Feb; 92(2):136-41. PubMed ID: 17298576
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Post-operative unwashed shed blood transfusion does not modify the cellular immune response to surgery for total knee replacement.
    Muñoz M; Cobos A; Campos A; Ariza D; Muñoz E; Gómez A
    Acta Anaesthesiol Scand; 2006 Apr; 50(4):443-50. PubMed ID: 16548856
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness.
    Dietrich W; Thuermel K; Heyde S; Busley R; Berger K
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):589-96. PubMed ID: 16202891
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Assessment of erythropoietin treatment in preterm newborns older than 30 weeks of gestation].
    Fontaine C; Cevallos L; Léké A; Krim G; Tourneux P
    Arch Pediatr; 2009 Apr; 16(4):331-6. PubMed ID: 19231142
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Finding the optimal regimen for short-term daily recombinant human erythropoietin treatment for blood-saving purpose in patients undergoing unilateral primary total hip arthroplasty: a double-blinded randomized placebo-controlled trial.
    Yuan M; Tao Q; Wang D; Wang H; Zhou Z
    BMC Musculoskelet Disord; 2022 Mar; 23(1):243. PubMed ID: 35279105
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antifibrinolytic therapy in complex spine surgery: a case-control study comparing aprotinin and tranexamic acid.
    Colomina MJ; Bagó J; Vidal X; Mora L; Pellisé F
    Orthopedics; 2009 Feb; 32(2):91. PubMed ID: 19301800
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients.
    Johansson T; Pettersson LG; Lisander B
    Acta Orthop; 2005 Jun; 76(3):314-9. PubMed ID: 16156456
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of preoperative autologous blood donation: analysis of blood loss and transfusion practice in total hip replacement.
    Billote DB; Glisson SN; Green D; Wixson RL
    J Clin Anesth; 2000 Nov; 12(7):537-42. PubMed ID: 11137415
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Leukodepletion of autologous whole blood has no impact on perioperative infection rate and length of hospital stay.
    Frietsch T; Karger R; Schöler M; Huber D; Bruckner T; Kretschmer V; Schmidt S; Leidinger W; Weiler-Lorentz A
    Transfusion; 2008 Oct; 48(10):2133-42. PubMed ID: 18564391
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
    Corapcioglu F; Aksu G; Basar EZ; Demirel A; Oncel S; Mutlu A
    Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Clinical comparative studies on effect of tranexamic acid on blood loss associated with total knee arthroplasty].
    Zhang F; Gao Z; Yu J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Dec; 21(12):1302-4. PubMed ID: 18277670
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antierythropoietin antibodies in thalassemia patients.
    Voulgari PV; Chaidos A; Tzouvara E; Alymara V; Alamanos Y; Drosos AA; Bourantas KL
    Ann Hematol; 2004 Jan; 83(1):22-7. PubMed ID: 14530877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.